Achieve Life Sciences, Inc.
ACHV
$2.92
-$0.06-2.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -50.42M | -46.16M | -39.83M | -32.94M | -27.54M |
| Total Depreciation and Amortization | 232.00K | 234.00K | 229.00K | 228.00K | 229.00K |
| Total Amortization of Deferred Charges | 23.00K | 37.00K | 23.00K | 9.00K | -- |
| Total Other Non-Cash Items | 8.93M | 7.90M | 7.39M | 6.69M | 6.70M |
| Change in Net Operating Assets | 1.51M | 2.42M | 2.41M | 1.08M | 906.00K |
| Cash from Operations | -39.72M | -35.57M | -29.77M | -24.95M | -19.71M |
| Capital Expenditure | -- | -- | -- | -6.00K | -21.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 43.04M | -10.23M | -21.58M | -33.30M | -46.57M |
| Cash from Investing | 43.04M | -10.23M | -21.58M | -33.30M | -46.59M |
| Total Debt Issued | 9.81M | 9.81M | 9.81M | 9.81M | -- |
| Total Debt Repaid | -18.11M | -18.11M | -18.11M | -18.11M | -- |
| Issuance of Common Stock | 42.09M | 865.00K | 56.98M | 56.29M | 56.11M |
| Repurchase of Common Stock | 0.00 | -153.00K | -153.00K | -153.00K | -153.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 33.79M | -7.58M | 48.53M | 47.85M | 55.96M |
| Foreign Exchange rate Adjustments | 0.00 | -2.00K | 0.00 | -2.00K | -4.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 37.12M | -53.38M | -2.82M | -10.41M | -10.35M |